Analyzing Costs Per Clinical Remission of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Rheumatoid Arthritis from a Public Perspective in Brazil
Abstract
Authors
C.T. Buschinelli M.F.M. Maximo C.T. Tsuchiya F.S. Tobaruella T.M. Gonçalves